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The need for increasing productivity in the discovery of new or novel drug-like compounds has resulted in the search for new techniques and strategies to streamline the drug discovery pipeline.
Central to this is the rapid identification of known compounds and analogues, a process known as chemical dereplication [1] [2] [3] enabling resources to be focused on extracts that can yield new or novel compounds. The most commonly employed methods involve the use of liquid chromatography coupled to a photodiode array detector and a high resolution mass spectrometer (LC-DAD-MS). 4, 5 The use of HRESIMS offers advantages over other methods, for example UV and NMR due to its high sensitivity and versatility, enabling it to produce more than one type of data in a single experiment such as positive, negative and fragmentation. However, determining molecular structures is more challenging and despite advances in MS technology, the process still needs NMR techniques to provide full structural information. Chemical dereplication methods available today use either one or both of these methods and generally fall into two main categories: targeted or non-targeted dereplication. Non-targeted chemical dereplication methods are less focused and often result in wasted time and resources due to reisolation of known compounds. Targeted chemical dereplication offers advantages as it allows resources to be utilized on isolation of new compounds or targeted isolation of known compounds for example with interesting biological activity. 4 For example LC-DAD-TOFMS was used to successfully identify known fungal metabolites by comparison of UV and MS data with reference standards. 6 The use of a database containing HRMS, MS/MS and UV data was used to rapidly identify the presence of aflatoxins which are nuisance mycotoxins in crude fungal extracts. 7 The use of MS/MS data to build molecular networks can identify compounds that are structurally related, 8, 9 but requires MS/MS data in integrated compound databases for their identification. Current MS/MS libraries containing experimental MS/MS data are known to cover only a limited number of natural products, estimated to be around 10%. 9 The combination of LCMS and phylogenetic finger printing was used in the targeted discovery of cyanobacterial compounds. 10 NMR spectroscopy, despite the problem of low sensitivity is increasingly being used for dereplication purposes. [11] [12] [13] The use of experimental LC retention time by comparing the retention time of an unknown with the retention time of a known standard compound is a commonly employed method of identifying compounds when used orthogonally with another data source like HRMS or MS/MS. 7, 14 However, it is not practical to purchase every known compound in the natural products database for measurement of experimental retention times considering the fact that there are about 250,000 of natural products 15 known to date. Use of predicted retention times, however is a possible alternative and has been studied for metabolite identification. 16 Prediction of retention times follows the concept of quantitative structure retention relationship (QSRR) which is based on the physicochemical nature of the analytecolumn interactions that determine retention. 17 It has been successfully applied to HPLC for identification of specific classes of compounds such as peptides, 18 steroids, 19 and lipids. 20 Application in chemically diverse group such as organic synthetic compounds has been carried out successfully, 21 but has yet to be applied in the identification of natural products. The huge diversity of structures in natural products is believed to be a challenge for any retention time prediction model, 16 but, it has the potential to work successfully as an extra filter when used with HRMS in a high throughput screening strategy to rapidly improve the identification of known natural products which is often one of the major bottle-necks 22 in drug discovery.
The goal of this study was to identify new natural products easily from Streptomyces sp. through rapid screening of known compounds held in a Streptomyces natural products database, StreDB. MbcDB. This database holds spectral data for 665 natural products from marine and terrestrial sources representing several classes of natural products such as peptides (30) Calculation of LC Retention Times. The LC-retention times of compounds in StrepDB were calculated using ACD/ChromGenius 25 The software uses physicochemical parameters like logP, logD, molecular weight (MW), molecular volume (MV), molar refractivity (MR), polar surface area (PSA), H-acceptors (NA), and H-donors (ND) to create a knowledge base using a set of 'training' compounds that had been measured previously. 25 To create the knowledge base, 417 natural products from MbcDB with structures, monoisotopic masses, and LCMS data (Figures S14, S15) were downloaded to ChromGenius. Calculations were performed for the method used (solvents, pH, temperature, column type, column size, and experimental LC-retention time) to build the prediction model. Retention times were predicted for each compound using the 10% most similar compounds in the knowledge base obtained by a Dice coefficient similarity search. 29 An overall correlation value (R 2 = 0.75) between the experimental and predicted retention times of the 417 standard compounds was obtained ( Figure 2) . Analysis of the data showed that 76% of the standard (training) compounds had retention time deviation (Table S61) . The model was then used to calculate the retention times of the 5,553 compounds held in StrepDB (Table 1 ). Dereplication using StrepDB. The Streptomyces strain used in this study was obtained from a soil sample from the University of Ghana, Africa and the subsequent construction of the legonmycin gene cluster, in-frame deletion and expression of the mutant strain have been described previously. 23 The crude sample of Streptomyces albus, ΔlgnC was fractionated into four fractions: water-butanol, water-methanol, dichloromethane, and hexane based on polarity using a modified Kupchan method. 30, 31 The four fractions were subjected to LCMS analysis, but only the water-butanol fraction was prioritized over the other three for compound isolation workup based on the amount (dried weight) of fraction and relative intensity of the ions to the quality control sample (reserpine). Data processing of this fraction and subsequent screening of StrepDB by IntelliXtract using a retention time window of 4.0 ( 2.0) minutes resulted in 71 masses between 200-500 Da, of which four masses were annotated as matching 10 compounds in StrepDB (Table S41 ). The structures of these compounds are easily displayed by switching to ' Table of Components' view ( Figure S42 ). The data suggested that the remaining 67 masses (94% of the total masses) were not in StrepDB, and were potentially new compounds. A UV profile filter was then applied manually to target only the compounds related to the legonindolizidines, 23 resulting in eleven masses with the expected UV profile (Table S16, Figure   S17 ). Inspection of the data indicated that one of the compounds of interest had been identified as legonindolizidine A ( Figure S42 ). (Table S41) or as a table of component containing structures (Table S42 ). The dark-green in the MS/Match column has indicated an excellent match with the compound adenine 9-beta-D-arabinofuranoside in StrepDB.
Isolation and Structure Determination. The water-butanol fraction was purified by a C18
HPLC column using a water-methanol gradient to afford the new compounds legonmaleimides A which were then ranked according to the differences between the experimental and calculated 13 C data. 35 The low chemical shift deviations of the HOSE-code (dA), 36 incremental Method (dI), 37 and Artificial Neural Networks (dN) 37 suggested that the proposed structure is correct. The top 25
candidates are shown in Figure S38 where the proposed candidate was placed at the number 1 position. A similar calculation performed for compound 2 yielded 92 possible structures. The top 25 candidates are shown in Figure S39 where the proposed structure for 2 was placed at the number 1 position.
Plausible biogenetic pathway. Compound 1 is likely to be derived from the biosynthetic intermediate legonindolizidine A 23 (3) through hydroxylation at C5, followed by ring rearrangement to generate a reactive aldehyde species 5, which is then oxidized to the corresponding carboxylic acid 1. Compound 1 is then reduced into 2 ( Figure 10 ). Compound 1 was tested against the human melanoma cell line A2058 and was found to be inactive (100% cell survival rate at 250 µM). Compound 2 has not been tested in any biological assay. nm. Semi-preparative HPLC purifications were performed using an ACE 5 C18, 250 x 100 mm column connected to an Agilent 1100 HPLC system consisting of a binary pump, degasser, photodiode array (DAD) and a preparative fraction collector. This system was also used to record the UV profile for measurement of the molar extinction coefficient (ɛ). IR was measured using a Perkin Elmer FT-IR (UATR Two) spectrometer. All solvents were of HPLC grade. by relating retention time to key predicted physicochemical parameters. The prediction accuracy of the knowledge base was estimated using a leave one out approach for each compound. 38 This knowledge base was then used to calculate the retention times of the compounds in StrepDB.
EXPERIMENTAL SECTION

General
Retention times were predicted using the 10% most similar compounds in the knowledge base obtained by a Dice coefficient similarity search. Isolation of the Legonmaleimides. The methanol extract of Streptomyces albus::minimal cassette ΔlgnC culture was dried and partitioned into four fractions: water-butanol, watermethanol, dichloromethane and hexane according to polarity. 30, 31 The water-butanol fraction was prioritised over the others and dereplicated using StrepDB based on sample dried weight, and compounds of interest based on HRMS and UV profile (Table S16, Figure S17 ). Final purification was performed by reversed phase HPLC using water and methanol as solvents. The gradient started from 95% Water to 50% MeOH in 20 minutes and then reached 100% MeOH in another 10 minutes before equilibration for a further 5 minutes in the starting solvents to yield legonmaleimide A (2.0 mg) and legonmaleimide B (1.5 mg).
Legonmaleimide A (1) 1 H and 13 C NMR data (CD3OD, 600 and 150 MHz, respectively), see 
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